| Old Articles: <Older 5261-5270 Newer> |
|---|
 |
The Motley Fool
November 21, 2008
Brian Orelli |
Manufacturing Pain Johnson & Johnson has plenty of it.   |
The Motley Fool
November 21, 2008
Brian Orelli |
Viagra Stays Behind the Counter All puns about soft sales and wishing something would go up in this market have been removed from this article. |
BusinessWeek
November 20, 2008 |
Financial Triage Innovative ways that hospitals are looking at patient finances. |
The Motley Fool
November 20, 2008
Brian Orelli |
Sanofi Breathing Easier Drugmaker Sanofi-Aventis settles a few patent disputes with generic-drugmaker nemeses. |
The Motley Fool
November 20, 2008
Brian Orelli |
Double Trouble for AstraZeneca A double dose of bad news for AstraZeneca. Current revenue is vanishing, and potential revenue is failing to materialize. |
The Motley Fool
November 20, 2008
Brian Orelli |
Like Coupons, Only Better Companies that provide medical products and services and are lowering their costs should do well in this environment. |
The Motley Fool
November 19, 2008
Brian Orelli |
Depressing News for Drugmakers Antidepressants aren't that different from each other, says a recent report. |
The Motley Fool
November 18, 2008
Brian Orelli |
No Buffer for Medtronic Even though sales grew for the quarter, investors weren't happy. |
The Motley Fool
November 18, 2008
Brian Orelli |
Genzyme Grounded for Thanksgiving The biotech won't get a decision on Myozyme until February. |
The Motley Fool
November 18, 2008
Brian Orelli |
Icahn's Next Biotech Adventure With ImClone done, he's got his eye focused elsewhere. |
| <Older 5261-5270 Newer> Return to current articles. |
